Aurka-to-P53 Signaling: A Link Between Stem Cell Regulation and Cancer, Mount Sinai School of Medicine Study

Published: Aug 06, 2012

Researchers at Mount Sinai School of Medicine, the University of Manchester, and the MD Anderson Cancer Center have found a new role for an oncogenic signaling pathway in embryonic stem cell (ESC) self-renewal and in reprogramming adult cells into an ESC-state, which will aid in the development of future cancer therapies.

Back to news